{"nct_id":"NCT04130997","title":"An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2019-11-18","start_date_type":"ACTUAL","primary_completion_date":"2030-02-01","primary_completion_date_type":"ESTIMATED","completion_date":"2030-02-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["TGTX"]}